Growth impairment in β-thalassemia major: The role of trace element deficiency and other potential factors

Peyman Eshghi, Samin Alavi, Saeed Ghavami, Armin Rashidi

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

A serious problem in thalassemia major is growth impairment for which several possible etiologies have been proposed. Sixty-seven patients with thalassemia were randomly enrolled into the study, divided into 2 groups with and without growth failure and the correlation between growth failure and the following parameters was evaluated: age, sex, serum ferritin level, serum zinc and copper concentrations, serum copper-zinc ratio, regularity of blood transfusion, and the regularity and duration of chelation therapy. Among all studied parameters, only age, duration, and type of chelation therapy and age of beginning chelation therapy were significantly different between the 2 groups. Binomial multivariate logistic regression showed that the only significant independent correlation was between age and growth failure. A 1-year increase in age is associated with a 1.57-fold increase in the risk of growth impairment. The results of this study indicated that a temporally cumulative damage to growth-mediating mechanisms except those considered here is responsible for growth failure in thalassemia major.

Original languageEnglish (US)
Pages (from-to)5-8
Number of pages4
JournalJournal of pediatric hematology/oncology
Volume29
Issue number1
DOIs
StatePublished - Jan 1 2007

Keywords

  • Chelation therapy
  • Growth failure
  • Thalassemia
  • Zinc deficiency

Fingerprint

Dive into the research topics of 'Growth impairment in β-thalassemia major: The role of trace element deficiency and other potential factors'. Together they form a unique fingerprint.

Cite this